Urosepsis: When UTI Spreads to Bloodstream – Recognition and Emergency Management

Definition

Urosepsis = sepsis (life-threatening organ dysfunction from dysregulated host response to infection) originating from a urinary tract infection. It is a medical emergency with mortality 20-40% if septic shock develops.

Pathogenesis

  1. Bacteria ascend urethra → bladder (cystitis) → ureters → kidneys (pyelonephritis).
  2. Renal parenchymal invasion → bacteremia (bacteria enter peritubular capillaries/venules).
  3. Systemic inflammatory response → cytokine storm (TNF-α, IL-1, IL-6) → vasodilation, capillary leak, coagulopathy, organ dysfunction.

Risk Factors

  • Host: Diabetes, immunocompromise (HIV, chemo, steroids), elderly, pregnancy, malignancy.
  • Anatomic/Functional: Obstruction (stones, BPH, stricture), neurogenic bladder, vesicoureteral reflux, indwelling catheter, stents.
  • Procedure-Related: Recent urologic instrumentation (cystoscopy, ureteroscopy, ESWL).
  • Pathogen: E. coli (70-80%), Klebsiella, Proteus, Enterococcus, Pseudomonas; ESBL/carbapenemase producers ↑ mortality.

Clinical Presentation (Sepsis-3 Criteria)

Sepsis (SOFA ≥2)Septic Shock
Fever/hypothermiaPersisting hypotension requiring vasopressors
Tachycardia (>90)Lactate >2 mmol/L (after fluids)
Tachypnea (>20) / PaCO₂ <32
Altered mental status
Leukocytosis/leukopenia/bandemia
UTI symptoms (dysuria, flank pain, frequency)

Diagnosis

  • Blood Cultures: 2 sets (aerobic/anaerobic) pre-antibiotics; urine culture simultaneously.
  • Lactate: Serial (q2-4h); clearance target ≥10%/2h.
  • Imaging: CT abdomen/pelvis (obstruction, abscess, stones, gas); US if radiation concern.
  • Labs: CBC, BMP, LFTs, coagulation, procalcitonin, ABG/VBG.

Emergency Management (Surviving Sepsis Campaign)

  1. Hour-1 Bundle:
    • Measure lactate; remeasure if >2.
    • Blood cultures before antibiotics.
    • Broad-spectrum IV antibiotics within 1 hour (e.g., piperacillin-tazobactam, meropenem, ceftriaxone + metronidazole – adjust for local resistance, allergy).
    • 30 mL/kg crystalloid bolus for hypotension/lactate ≥4.
    • Vasopressors (norepinephrine first-line) if hypotensive after fluids.
  2. Source Control: Relieve obstruction (nephrostomy, stent, Foley) within 6-12 hours – critical for urosepsis.
  3. Supportive: Mechanical ventilation, renal replacement therapy, stress-dose steroids (if refractory shock), nutrition.

Complications

  • Acute kidney injury (ATN, cortical necrosis) – may need dialysis.
  • Acute respiratory distress syndrome (ARDS).
  • Disseminated intravascular coagulation (DIC).
  • Adrenal insufficiency.
  • Multiorgan failure.

Prevention

  • Catheter stewardship (avoid, early removal, aseptic insertion).
  • Prompt UTI treatment (culture-guided).
  • Obstruction management (stones, BPH).
  • Peri-procedural antibiotic prophylaxis.
  • Glycemic control in diabetics.

Urosepsis demands rapid recognition, immediate antibiotics, aggressive resuscitation, and urgent source control. Delayed intervention exponentially increases mortality.

Urine Therapy - Related Articles